Current Edition


‘No small feat’: Albireo CEO talks biotech’s commercial transition amid Bylvay launch

Established in Sweden as a small spinout of AstraZeneca in 2008, Albireo always had big ambitions. After all, it was named after the striking “double …

Continue Reading →

Eyeing its post-Humira future, AbbVie angles for broader Rinvoq use in U.S., Europe

Despite classwide safety worries in the U.S., AbbVie is making strides in its quest to build immunology up-and-comer Rinvoq. AbbVie sent off applications to U.S. and …

Continue Reading →

AstraZeneca strikes COVID-19 vaccine delivery deal with Europe, ending high-profile legal battle

At times during the pandemic, there’s been no love lost between AstraZeneca and the EU. After the U.K. pharma giant fell behind on its planned …

Continue Reading →